Bone Marrow Transplantation Unit Department of Pediatric Hematology and Oncology National Institute of Children's Diseases Bratislava Slovakia

Department Haematology Oncology Immunology Gene Therapy and Stem Cell Transplantation University Children's Hospital Zurich Switzerland

Department of Hematology Oncology and General Pediatrics Children's University Hospital University of Tübingen Tübingen Germany

Department of Pediatric Hematology and Oncology Bambino Gesù Children's Hospital Catholic University of the Sacred Heart Rome Italy

Department of Pediatric Hematology and Oncology BMT Unit CIC 817 Wroclaw Medical University Wroclaw Poland

Department of Pediatric Hematology and Oncology Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology Oslo University Hospital Oslo Norway

Department of Pediatric Hematology and Stem Cell Transplantation Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases Budapest Hungary

Department of Pediatric Hematology Oncology and Stem Cell Transplantation Ghent University Hospital Ghent Belgium

Department of Pediatric Oncology Hematology Skåne University Hospital Lund Sweden

Department of Pediatrics Aarhus University Hospital Aarhus Denmark

Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology and Oncology Medical Center Faculty of Medicine University of Freiburg Freiburg Germany

Department of Pediatrics St Anna Children's Hospital Medical University of Vienna Vienna Austria

Department of Stem Cell Transplantation Princess Máxima Centre Utrecht The Netherlands

Division of Hematology Oncology and SCT New Children´s Hospital University of Helsinki and Helsinki University Hospital Helsinki Finland

Division of Pediatric Stem Cell Therapy Department for Pediatric Oncology Hematology and Clinical Immunology Medical Faculty Heinrich Heine University Düsseldorf Germany

German Cancer Consortium Heidelberg and Freiburg Freiburg Germany

Institute of Cell and Molecular Pathology Hannover Medical School Hannover Germany

Paediatric Haematology and Oncology Fondazione IRCCS Policlinico San Matteo Pavia Italy

Pediatric Haematology Our Lady's Children's Hospital Dublin Ireland

Pediatric hematopoietic stem cell transplantation and immunodeficiency The Child and Adolescent Department Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Pediatric Oncology and Hematology IRCCS Azienda Ospedaliero Universitaria di Bologna Bologna Italy

Pediatric Oncology and Hematology Service Hematopoietic Stem Cell Transplantation Section Vall d'Hebron University Hospital Barcelona Spain

Princess Maxima Center Diagnostic Laboratory DCOG Laboratory Utrecht The Netherlands

Stem Cell Transplantation Unit Willem Alexander Children's Hospital Leiden University Medical Center Leiden The Netherlands

Zobrazit více v PubMed

Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: Who’s the driver at the wheel? Blood. 2019;133:1060–70. doi: 10.1182/blood-2018-11-844688. PubMed DOI

Locatelli F, Nöllke P, Zecca M, Korthof E, Lanino E, Peters C, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): Results of the EWOG-MDS/EBMT trial. Blood. 2005;105:410–9. doi: 10.1182/blood-2004-05-1944. PubMed DOI

Yoshida N, Sakaguchi H, Yabe M, Hasegawa D, Hama A, Hasegawa D, et al. Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020;26:902–10. doi: 10.1016/j.bbmt.2019.11.029. PubMed DOI

Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood. 1997;89:3534–43. PubMed

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015;47:1326–33. doi: 10.1038/ng.3400. PubMed DOI PMC

Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, Nöllke P, et al. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017;8:2126. PubMed PMC

Yoshimi A, Bader P, Matthes-Martin S, Starý J, Sedlacek P, Duffner U, et al. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia. 2005;19:971–7. doi: 10.1038/sj.leu.2403721. PubMed DOI

Yoshimi A, Mohamed M, Bierings M, Urban C, Korthof E, Zecca M, et al. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia. 2007;21:556–60. doi: 10.1038/sj.leu.2404537. PubMed DOI

Schonung M, Meyer J, Nollke P, Olshen AB, Hartmann M, Murakami N, et al. International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia. Clin Cancer Res. 2021;27:158–68. doi: 10.1158/1078-0432.CCR-20-3184. PubMed DOI PMC

Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, Van Den Heuvel-Eibrink MM, et al. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015;125:2311–3. doi: 10.1182/blood-2015-01-619734. PubMed DOI

Niemeyer CM, Flotho C, Lipka DB, Stary J, Rössig C, Baruchel A, et al. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial. Blood Adv. 2021;5:2901–8. doi: 10.1182/bloodadvances.2020004144. PubMed DOI PMC

Huschart E, Miller H, Salzberg D, Campbell C, Beebe K, Schwalbach C, et al. Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia. Pediatr Hematol Oncol. 2021;38:154–60. doi: 10.1080/08880018.2020.1829220. PubMed DOI